Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Gupta

Showing results (291-300 of 353) with videos related to

Pageof 36
Sort By:
Targeted Oncology|April 12, 2022
Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological MalignanciesToshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin, et al.
Investigational New Drugs|August 6, 2022
Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumorsXiaofei Zhou, Ulka Vaishampayan, Devalingam Mahalingam, et al.
Global Spine Journal|March 31, 2025
Does the Lumbar Paraspinal Muscle Status Have a Role in Predicting Mechanical Complications After Adult Spinal Deformity Surgery?Ganesh Kumar, Vikas Tandon, Ankur Nanda, et al.
The Journal of Vascular Access|February 6, 2026
Safety and efficacy of interventions for pain management during venipuncture in neonates: A systematic review and network meta-analysisNalina Amuji, Bharathi Balachander, Thangaraj Abiramalatha, et al.
Journal of Clinical Pharmacology|February 19, 2025
Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR -1, -2, and -3, in Patients with Refractory Metastatic Colorectal CancerXiaofei Zhou, Xiaoyan Yang, Boris Grinshpun, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|September 8, 2011
Evaluation of a single-channel portable monitor for the diagnosis of obstructive sleep apneaBurcu Oktay, Thomas B Rice, Charles W Atwood, et al.
Investigational New Drugs|September 22, 2017
A phase I study to assess the mass balance, excretion, and pharmacokinetics of [<sup>14</sup>C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumorsNeeraj Gupta, Steven Zhang, Sandeepraj Pusalkar, et al.
Clinical Pharmacology and Therapeutics|January 14, 2018
Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic UseSatyaprakash Nayak, Oliver Sander, Nidal Al-Huniti, et al.
British Journal of Clinical Pharmacology|April 29, 2016
Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairmentNeeraj Gupta, Michael J Hanley, Karthik Venkatakrishnan, et al.
World Journal of Pediatrics : WJP|February 3, 2016
Feasibility and efficacy of gentamicin for treating neonatal sepsis in community-based settings: a systematic reviewNishant Jaiswal, Meenu Singh, Ritika Kondel, et al.
Pageof 36

Showing results (291-300 of 353) with videos related to

Sort By:
Pageof 36
Targeted Oncology|April 12, 2022
Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological MalignanciesToshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin, et al.
Investigational New Drugs|August 6, 2022
Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumorsXiaofei Zhou, Ulka Vaishampayan, Devalingam Mahalingam, et al.
Global Spine Journal|March 31, 2025
Does the Lumbar Paraspinal Muscle Status Have a Role in Predicting Mechanical Complications After Adult Spinal Deformity Surgery?Ganesh Kumar, Vikas Tandon, Ankur Nanda, et al.
The Journal of Vascular Access|February 6, 2026
Safety and efficacy of interventions for pain management during venipuncture in neonates: A systematic review and network meta-analysisNalina Amuji, Bharathi Balachander, Thangaraj Abiramalatha, et al.
Journal of Clinical Pharmacology|February 19, 2025
Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR -1, -2, and -3, in Patients with Refractory Metastatic Colorectal CancerXiaofei Zhou, Xiaoyan Yang, Boris Grinshpun, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|September 8, 2011
Evaluation of a single-channel portable monitor for the diagnosis of obstructive sleep apneaBurcu Oktay, Thomas B Rice, Charles W Atwood, et al.
Investigational New Drugs|September 22, 2017
A phase I study to assess the mass balance, excretion, and pharmacokinetics of [<sup>14</sup>C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumorsNeeraj Gupta, Steven Zhang, Sandeepraj Pusalkar, et al.
Clinical Pharmacology and Therapeutics|January 14, 2018
Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic UseSatyaprakash Nayak, Oliver Sander, Nidal Al-Huniti, et al.
British Journal of Clinical Pharmacology|April 29, 2016
Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairmentNeeraj Gupta, Michael J Hanley, Karthik Venkatakrishnan, et al.
World Journal of Pediatrics : WJP|February 3, 2016
Feasibility and efficacy of gentamicin for treating neonatal sepsis in community-based settings: a systematic reviewNishant Jaiswal, Meenu Singh, Ritika Kondel, et al.
Pageof 36